ATC code L02

ATC codes
L Antineoplastic and immunomodulating agents
	L01 Antineoplastic agents
	L02 Endocrine therapy
	L03 Immunostimulants
	L04 Immunosuppressants
A B C D G H QI J L M N P R S V ; (Hover over links to see titles) ;

ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.<ref>

ATC/DDD Index 2022

code L02(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL02.<ref>

ATCvet Index 2022

code QL02(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L02A Hormones and related agents[edit]

L02AE51 Leuprorelin and bicalutamide

L02AX Other hormones[edit]

L02B Hormone antagonists and related agents[edit]

L02BA Anti-estrogens[edit]

L02BA01 Tamoxifen

L02BA02 Toremifene

L02BA03 Fulvestrant

L02BB Anti-androgens[edit]

L02BB01 Flutamide

L02BB02 Nilutamide

L02BB03 Bicalutamide

L02BB04 Enzalutamide

L02BB05 Apalutamide

L02BG Aromatase inhibitors[edit]

L02BG01 Aminogluthetimide

L02BG02 Formestane

L02BG03 Anastrozole

L02BG04 Letrozole

L02BG05 Vorozole

L02BG06 Exemestane

L02BX Other hormone antagonists and related agents[edit]

L02BX01 Abarelix

L02BX02 Degarelix

L02BX03 Abiraterone

References[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian